LEGAL PROCEEDINGS (Details) (USD $) In Millions, unless otherwise specified	1 Months Ended	3 Months Ended	1 Months Ended					0 Months Ended	1 Months Ended
	Feb. 28, 2010 Aplenzin Watson	Mar. 31, 2012 Aplenzin Watson action patent	Mar. 31, 2012 Bupropion Hydrobromide Tablets Sandoz	Jan. 31, 2012 Fluorouracil topical cream, 0.5% Spear Pharmaceuticals, Inc	May 31, 2008 Written plea agreement Biovail Pharmaceuticals, Inc.	May 31, 2008 Non-prosecution agreement Biovail Pharmaceuticals, Inc.	Sep. 30, 2009 Corporate Integrity Agreement Biovail Pharmaceuticals, Inc.	Dec. 13, 2009 False Claims Act Biovail Pharmaceuticals, Inc. defendant	Oct. 31, 2009 General civil actions case
Legal proceedings and other matters
Penalty fees					$ 22.2	$ 2.4
Obligation term (in years)							5 years
Period of stay on approval (in months)	30 months		30 months	30 months
Number of actions consolidated into the first-filed case		2
Number of the patents that remain in the litigation		5
Number of cases settled									3
Maximum amount of consideration paid under settlement agreement									$ 0.10
Number of other companies named as defendants								20